Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
15.25
-0.18 (-1.13%)
At close: Oct 6, 2025, 4:00 PM EDT
15.22
-0.02 (-0.16%)
After-hours: Oct 6, 2025, 4:00 PM EDT

Denali Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,2292,9332,9663,7775,44710,044
Upgrade
Market Cap Growth
-49.40%-1.10%-21.48%-30.66%-45.77%500.43%
Upgrade
Enterprise Value
1,2991,7041,9022,7334,1539,133
Upgrade
Last Close Price
15.2220.3821.4627.8144.6083.76
Upgrade
PE Ratio
-----141.20
Upgrade
PS Ratio
--8.9734.82111.9329.92
Upgrade
PB Ratio
2.162.382.883.625.668.73
Upgrade
P/TBV Ratio
2.172.382.883.625.668.73
Upgrade
P/FCF Ratio
-----24.32
Upgrade
P/OCF Ratio
-----24.14
Upgrade
EV/Sales Ratio
--5.7625.2085.3527.21
Upgrade
EV/EBITDA Ratio
-----128.18
Upgrade
EV/EBIT Ratio
-----145.62
Upgrade
EV/FCF Ratio
-----22.11
Upgrade
Debt / Equity Ratio
0.050.040.050.060.070.06
Upgrade
Debt / EBITDA Ratio
-----0.87
Upgrade
Debt / FCF Ratio
-----0.17
Upgrade
Asset Turnover
--0.250.080.030.31
Upgrade
Quick Ratio
9.898.1613.313.702.2920.58
Upgrade
Current Ratio
10.278.4613.653.772.3720.86
Upgrade
Return on Equity (ROE)
-39.69%-37.40%-14.01%-32.52%-27.51%9.21%
Upgrade
Return on Assets (ROA)
-24.99%-24.82%-9.40%-14.87%-12.29%3.63%
Upgrade
Return on Capital (ROIC)
-26.56%-26.50%-11.25%-20.00%-16.46%4.65%
Upgrade
Return on Capital Employed (ROCE)
-----4.10%
Upgrade
Earnings Yield
-21.50%-14.41%-4.90%-8.63%-5.33%0.71%
Upgrade
FCF Yield
-16.51%-12.40%-12.51%-6.95%-4.04%4.11%
Upgrade
Buyback Yield / Dilution
-14.84%-19.73%-9.43%-3.30%-7.83%-17.88%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q